Skip to content

Prospective observational study of sarcopenia in patients with malignant lymphoma

Prospective observational study of sarcopenia in patients with malignant lymphoma - sarcopenia in lymphoma patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000017109
Enrollment
80
Registered
2015-04-12
Start date
2015-04-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant lymphoma

Interventions

None listed

Sponsors

Department of Hematology Yokohama Municipal Citizen's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients with histologically-confirmed malignant lymphoma 2)Patients who received informed consent 3)Untreated patients 4)>=20 years old 5)Written informed consent form prior to participation in the study

Exclusion criteria

Exclusion criteria: 1)Ptients with consciousness disturbance 2)Patients with severe physical dysfunction 3)Patients with severe mental disorder 4)Patients with pacemaker 5)Patients with pregnancy 6)Patients who can not stand continuously for 90 seconds 7)Patients that attending doctors judge to be inappropriate to perform this study

Design outcomes

Primary

MeasureTime frame
Changes in body composition(Skeltal muscle mass, Body fat mass)

Secondary

MeasureTime frame
Overall survival Progression free survival Early mortality Response rate Adverse event

Countries

Japan

Contacts

Public ContactTomonori Nakazato

Yokohama Municipal Citizen's Hospital Department of Hematology

n-tomo@eurus.dti.ne.jp045-331-1961

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026